MedPath

NAPROSYN SUP 500MG

NAPROSYN SUP 500MG

Discontinued
DIN Number

00531022

Drug Class

Human

Market Date

Dec 31, 1984

Company
HC

syntex inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number00531022
AIG Number0109634003
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
M01AE02 NAPROXEN
Product Specifications
Dosage FormSuppository
Route of AdministrationRectal
AHFS Classification28:08.04.92
Health Canada Classification

ACTIVE INGREDIENTS (1)

NAPROXENActive
Strength: 500 MG / SUP
Monograph: NAPROXEN

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.